Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PASSIVATE: AZD5718 in Acute Coronary Syndrome
NCT04601467Phase 2Terminated
- Sponsor
- National University Heart Centre, Singapore
- Start
- Jul 2021
- Primary completion
- May 2024
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 2, randomised, double-blind trial in acute coronary syndrome (ACS) comparing AZD5718 with Placebo (2 arms). Primary endpoint: Change in noncalcified coronary artery plaque volume at 12 months. Started Jul 2021; status: terminated.
02
Drugs
atuliflapon
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on NCT04601467.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04601467.